Quarterly Result13 Aug 2026, 11:47 am
Lincoln Pharmaceuticals Declares Un-Audited Q1 FY27 Results
AI Summary
Lincoln Pharmaceuticals Ltd announced its un-audited financial results for the quarter ended June 30, 2026. The company's Board of Directors approved the standalone and consolidated results. The results were published in accordance with SEBI Listing Regulations and are available on the company's website. The financial highlights for the quarter were also enclosed with the filing.
Key Highlights
- Un-audited financial results for Q1 FY27 declared.
- Results are standalone and consolidated.
- Board of Directors approved the financial results.
- Limited review report from auditors is included.
- Results available on the company website.
Price Impact
More from LINCOLN